在社区居住的老年人中患上萨科佩尼亚的患病率和相关因素:系统性审查和元分析
Leixia Wang1, Jianqian Chao2, Na Zhang3
1Health Management Research Center, School of Public Health, Southeast University, Nanjing, China.
Gerontology
|December 4, 2025
概括
麻症影响近19%的老年人,患病率因诊断方法和地区而异. 关键风险包括老年,低BMI,营养不良,不活动和并发症,突出了对标准化诊断和干预措施的需求.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 萨科佩尼亚是一种严重的老年综合征,与老年人不良健康结果有关.
- 了解其流行率和风险因素对于制定有效的预防策略至关重要.
研究的目的:
- 系统地审查和元分析社区居住的老年人中肉类的患病率.
- 在这个人群中识别与肉症相关的因素.
主要方法:
- 在六个数据库中进行系统的文献搜索,遵循PICo框架.
- 对52项研究 (70,202名参与者) 的元分析,以估计患病率和风险因素的合并几率比率.
- 由两个审稿人进行的独立质量评估.
主要成果:
- 总体上,萨科佩尼亚患病率估计为18.8% (95%CI:15.6%-22.4%),具有显著的异质性.
- 患病率差异很大 (5.2%-50.0%) 和高于EWGSOP 2018标准 (25.8%).
- 显著的危险因素包括老年,低BMI,营养不良,体力活动低,吸烟,骨质疏松症,关节炎,抑郁症,糖尿病和认知障碍.
结论:
- 在社区居住的老年人中,高且异质的麻症患病率,受诊断方法和地区的影响.
- 确定了关键可修改的风险因素,如营养不良,体力活动不足和并发症.
- 强调需要标准化诊断标准和早期,基于社区的干预措施.
相关概念视频
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
183
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183
Changes in the Appendicular Skeleton with Age
3.3K
The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.3K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
216
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
216
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
212
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212


